The company has designed the Air Pro device for the protection of larger spaces and open floor plans up to 1,000ft²
Molekule has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its existing air purifier Air Pro as a Class II medical device.
Air Pro device is now approved for medical use to destruct viruses, bacteria, and mold.
The device is said to join the company’s Air Mini, Air Mini+, and Air Pro RX products, which are also FDA approved for medical use, including in the home, to destruct viruses and bacteria in particular.
Molekule CEO Jonathan Harris said: “We are proud to add the FDA’s clearance to another Molekule device. In the wake of so many air quality concerns right now, it has become increasingly important for people to feel confident in the products they choose to help keep the air they breathe cleaner.
“The FDA clearance of our fourth product is another huge milestone in validating our PECO air purification technology as a trusted addition to any home, office space, school, or medical facility.”
The patented Photo Electrochemical Oxidation (PECO) technology is used by the company’s air purification devices.
Molekule’s PECO technology holds the potential to eradicate microscopic pollutants such as viruses, bacteria, mold, allergens, and chemicals.
The company has designed the Air Pro for the protection of larger spaces and open floor plans up to 1,000ft².
With increased air flow compared to Molekule’s other air purifiers, the Air Pro also consists of finely tuned sensor capability to categorise detected particles into three sizes ranging from PM10 (pollen) and PM2.5 (dust) to smaller than PM1 (smoke).
Designed to simply plug into the wall, the Air Pro is said to have demonstrated to the FDA that it can achieve greater than 4-log or 99.99%, reduction of RNA virus MS2 within 30 minutes.